Page last updated: 2024-09-03

pramipexole and aminoglutethimide

pramipexole has been researched along with aminoglutethimide in 1 studies

Compound Research Comparison

Studies
(pramipexole)
Trials
(pramipexole)
Recent Studies (post-2010)
(pramipexole)
Studies
(aminoglutethimide)
Trials
(aminoglutethimide)
Recent Studies (post-2010) (aminoglutethimide)
1,1032195171,48913556

Protein Interaction Comparison

ProteinTaxonomypramipexole (IC50)aminoglutethimide (IC50)
AromataseHomo sapiens (human)5.043
Ribosyldihydronicotinamide dehydrogenase [quinone]Homo sapiens (human)0.27
AromataseRattus norvegicus (Norway rat)6.2
Delta-type opioid receptorMus musculus (house mouse)0.27

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1

Other Studies

1 other study(ies) available for pramipexole and aminoglutethimide

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013